z-logo
open-access-imgOpen Access
Comparative evaluation of mutational and mRNA expression pattern of pulmonary cytokines after infection with Aspergillus flavus and Aspergillus fumigatus
Author(s) -
Jehane I. Eid,
Heba M. Abdelraouf,
Tarig Abdelrahman,
Akmal A. El-Ghor
Publication year - 2014
Publication title -
disease and molecular medicine
Language(s) - English
Resource type - Journals
ISSN - 2147-6748
DOI - 10.5455/dmm.20140519115524
Subject(s) - aspergillus flavus , aspergillus , aspergillus fumigatus , medicine , microbiology and biotechnology , immunology , biology
Invasive pulmonary aspergillosis (IPA) is a lethal complication of persistent neutropenia. In the pathogenesis of IPA, proinflammatory cytokine seems to play a key role. However, little progress has been made in comparing the production of pulmonary cytokines in mice with IPA caused by A. fumigatus versus A. flavus at the molecular level. Therefore, it was our aim to investigate the mutational and expression pattern of proinflammatory cytokine encoding genes in the lung of immunocompetent and immunocompromised mice infected with either species. The levels of mutational events and transcription of IL-1beta and IL-6 encoding genes in the pulmonary tissues of infected mice (with or without immunosuppression) were compared by means of semi-quantitative polymerase chain reaction and PCR-SSCP. Pulmonary fungal burden and histopathological changes were also assessed. The degree of DNA degredation and amounts of pulmonary IL-1beta and IL-6 induced by A. fumigatus were much higher than those produced by A. flavus. The differential expressions of cytokines by two species were not associated with any mutational events within the selected sequences of the cytokines encoding genes. Our data may explain why A. fumigatus, but less commonly A. flavus, cause IPA and also confirm the contribution of DNA degradation pattern associated with severe inflammation to the pathogenesis of IPA. [Dis Mol Med 2014; 2(2.000): 32-40

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here